Clinical Trials | February 10, 2022
Skye Air Mobility to deploy drones to enhance Redcliffe Labs services
Urban, semi-urban and remote corners of the country will be catered using drone delivery technology
Urban, semi-urban and remote corners of the country will be catered using drone delivery technology
Takes charge to lead business innovation, strategy, alliance & partnerships
Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies
It plans to add over 1000 employees over the next six months
Both companies aim to improve the efficiency and success rate of the current drug discovery process.
Efdoralprin Alfa was well tolerated, with a safety profile comparable to plasma-derived therapy
Takeda will make an upfront payment of $1.2 billion, which includes a $100 million equity investment in Innovent
Global Phase 3 MANEUVER study highlights ongoing benefits and consistent safety profile
Based on these promising results, Johnson & Johnson plans to move the program into a Phase 3 trial to further investigate subcutaneous amivantamab
The SELECT-SWITCH study, first head-to-head Phase 3b/4 trial, compared switching to Rinvoq versus switching to another TNF inhibitor
Subscribe To Our Newsletter & Stay Updated
